Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study.
Monti M, Degenhardt T, Brain E, Wuerstlein R, Argusti A, Puntoni M, Rollandi GA, Corradengo D, Boni L, Ilhan H, Nanni O, Cortes J, Piris-Gimenez A, Piccardo A, Iacozzi M, Matteucci F, Di Iorio V, Alberini JL, Schröder C, Harbeck N, Gennari A. Monti M, et al. Among authors: argusti a. Front Med (Lausanne). 2022 Jan 13;8:817678. doi: 10.3389/fmed.2021.817678. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35096909 Free PMC article.
Clinical trials with retinoids for breast cancer chemoprevention.
Zanardi S, Serrano D, Argusti A, Barile M, Puntoni M, Decensi A. Zanardi S, et al. Among authors: argusti a. Endocr Relat Cancer. 2006 Mar;13(1):51-68. doi: 10.1677/erc.1.00938. Endocr Relat Cancer. 2006. PMID: 16601279 Review.
Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies.
Zanardi S, Puntoni M, Maffezzini M, Bandelloni R, Mori M, Argusti A, Campodonico F, Turbino L, Branchi D, Montironi R, Decensi A. Zanardi S, et al. Among authors: argusti a. Cancer Prev Res (Phila). 2009 Apr;2(4):377-84. doi: 10.1158/1940-6207.CAPR-08-0205. Epub 2009 Mar 31. Cancer Prev Res (Phila). 2009. PMID: 19336728 Free article. Clinical Trial.
A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma.
Puntoni M, Branchi D, Argusti A, Zanardi S, Crosta C, Meroni E, Munizzi F, Michetti P, Coccia G, De Roberto G, Bandelloni R, Turbino L, Minetti E, Mori M, Salvi S, Boccardo S, Gatteschi B, Benelli R, Sonzogni A, DeCensi A. Puntoni M, et al. Among authors: argusti a. Cancer Prev Res (Phila). 2013 Feb;6(2):74-81. doi: 10.1158/1940-6207.CAPR-12-0249. Epub 2012 Dec 4. Cancer Prev Res (Phila). 2013. PMID: 23213070 Clinical Trial.
SERMs in chemoprevention of breast cancer.
Gasco M, Argusti A, Bonanni B, Decensi A. Gasco M, et al. Among authors: argusti a. Eur J Cancer. 2005 Sep;41(13):1980-9. doi: 10.1016/j.ejca.2005.04.017. Eur J Cancer. 2005. PMID: 15964182 Review.
Fenretinide and risk reduction of second breast cancer.
Decensi A, Zanardi S, Argusti A, Bonanni B, Costa A, Veronesi U. Decensi A, et al. Among authors: argusti a. Nat Clin Pract Oncol. 2007 Feb;4(2):64-5. doi: 10.1038/ncponc0735. Nat Clin Pract Oncol. 2007. PMID: 17259924 Clinical Trial. No abstract available.
A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Colombo N, Formelli F, Cantù MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, Decensi A. Colombo N, et al. Among authors: argusti a. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1914-9. doi: 10.1158/1055-9965.EPI-06-0183. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035399 Clinical Trial.
18 results